NCT06528613View on ClinicalTrials.gov

Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Benign Prostatic Hyperplasia
Trial Locations (6)

15126

NOT_YET_RECRUITING

Second Department of Urology, Sismanoglio Hospital, Athens, Greece., Athens

24100

RECRUITING

Department of Urology, General Hospital of Messinia, Kalamata

26504

RECRUITING

Department of Urology, University Hospital of Rion, Pátrai

41221

RECRUITING

Department of Urology, General Hospital of Larissa, Larissa

54635

RECRUITING

First Department of Urology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki

71409

RECRUITING

Department of Urology, Venizelio General Ηospital, Heraklion

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY